松霖科技(603992.SH):未來美容健康品類的產品收入結構波動可能會更為明顯
格隆匯10月16日丨松霖科技(603992.SH)投資者關係活動記錄表顯示,近兩年美容健康品類的產品收入主要來自美容花灑和美容儀,隨着新產品如美容儀、健發儀、脱毛儀和射頻儀等的開發與推出及新項目的逐步落地,將持續推動營收增長,而隨着各產品類別增加、收入增長不同,原本收入佔比較高的美容花灑將逐漸降低。
目前各類別的產品基礎規模不大,因此未來美容健康品類的產品收入結構波動可能會更為明顯。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.